CN115024412A - Functional compound for promoting growth of piglets and preparation method and application thereof - Google Patents
Functional compound for promoting growth of piglets and preparation method and application thereof Download PDFInfo
- Publication number
- CN115024412A CN115024412A CN202210672320.6A CN202210672320A CN115024412A CN 115024412 A CN115024412 A CN 115024412A CN 202210672320 A CN202210672320 A CN 202210672320A CN 115024412 A CN115024412 A CN 115024412A
- Authority
- CN
- China
- Prior art keywords
- parts
- inulin
- piglet
- dioleic
- polysaccharide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 63
- 150000001875 compounds Chemical class 0.000 title claims abstract description 26
- 230000001737 promoting effect Effects 0.000 title claims abstract description 18
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 67
- 239000005017 polysaccharide Substances 0.000 claims abstract description 67
- 229920001202 Inulin Polymers 0.000 claims abstract description 66
- 229940029339 inulin Drugs 0.000 claims abstract description 66
- -1 inulin short-chain fatty acid ester Chemical class 0.000 claims abstract description 29
- 244000077995 Coix lacryma jobi Species 0.000 claims abstract description 18
- 235000019198 oils Nutrition 0.000 claims abstract description 17
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract description 17
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000002994 raw material Substances 0.000 claims abstract description 15
- 235000002568 Capsicum frutescens Nutrition 0.000 claims abstract description 14
- 108010011619 6-Phytase Proteins 0.000 claims abstract description 12
- 229940085127 phytase Drugs 0.000 claims abstract description 12
- LPOSZYSKJWFIQH-UHFFFAOYSA-N 2-aminoacetic acid;iron Chemical compound [Fe].NCC(O)=O LPOSZYSKJWFIQH-UHFFFAOYSA-N 0.000 claims abstract description 9
- 150000004676 glycans Chemical class 0.000 claims description 58
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 47
- 229920001491 Lentinan Polymers 0.000 claims description 18
- 241000219823 Medicago Species 0.000 claims description 18
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 claims description 18
- 229940115286 lentinan Drugs 0.000 claims description 18
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims description 17
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 17
- 240000002547 Rosa roxburghii Species 0.000 claims description 17
- 235000000640 Rosa roxburghii Nutrition 0.000 claims description 17
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 16
- 240000000588 Hericium erinaceus Species 0.000 claims description 16
- 235000007328 Hericium erinaceus Nutrition 0.000 claims description 16
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 15
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
- 239000005018 casein Substances 0.000 claims description 9
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 9
- 235000021240 caseins Nutrition 0.000 claims description 9
- 239000008101 lactose Substances 0.000 claims description 9
- 229940071440 soy protein isolate Drugs 0.000 claims description 9
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 240000008574 Capsicum frutescens Species 0.000 claims description 3
- 235000002566 Capsicum Nutrition 0.000 claims description 2
- 239000001390 capsicum minimum Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000006116 polymerization reaction Methods 0.000 claims description 2
- 238000005507 spraying Methods 0.000 claims description 2
- 230000000968 intestinal effect Effects 0.000 abstract description 26
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 14
- 206010012735 Diarrhoea Diseases 0.000 abstract description 9
- 238000010521 absorption reaction Methods 0.000 abstract description 9
- 235000015097 nutrients Nutrition 0.000 abstract description 8
- 230000029087 digestion Effects 0.000 abstract description 7
- 239000000126 substance Substances 0.000 abstract description 5
- 208000007502 anemia Diseases 0.000 abstract description 4
- 230000018109 developmental process Effects 0.000 description 12
- 230000000694 effects Effects 0.000 description 11
- 230000002195 synergetic effect Effects 0.000 description 9
- 230000000052 comparative effect Effects 0.000 description 8
- 150000004666 short chain fatty acids Chemical class 0.000 description 7
- 230000007413 intestinal health Effects 0.000 description 6
- 238000013329 compounding Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 241000218033 Hibiscus Species 0.000 description 4
- 235000005206 Hibiscus Nutrition 0.000 description 4
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 150000004667 medium chain fatty acids Chemical class 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 230000007358 intestinal barrier function Effects 0.000 description 3
- 210000001630 jejunum Anatomy 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 210000004877 mucosa Anatomy 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 150000003626 triacylglycerols Chemical class 0.000 description 3
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 244000271246 Cedrela sinensis Species 0.000 description 2
- 235000011783 Cedrela sinensis Nutrition 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000282887 Suidae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 210000001198 duodenum Anatomy 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 235000020256 human milk Nutrition 0.000 description 2
- 210000004251 human milk Anatomy 0.000 description 2
- 210000003405 ileum Anatomy 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- GIPOFCXYHMWROH-UHFFFAOYSA-L 2-aminoacetate;iron(2+) Chemical compound [Fe+2].NCC([O-])=O.NCC([O-])=O GIPOFCXYHMWROH-UHFFFAOYSA-L 0.000 description 1
- AKLSSKNRPSKJBO-UHFFFAOYSA-K 2-aminoacetate;iron(3+) Chemical compound [Fe+3].NCC([O-])=O.NCC([O-])=O.NCC([O-])=O AKLSSKNRPSKJBO-UHFFFAOYSA-K 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 244000062241 Kaempferia galanga Species 0.000 description 1
- 235000013421 Kaempferia galanga Nutrition 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 235000013628 Lantana involucrata Nutrition 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 206010025476 Malabsorption Diseases 0.000 description 1
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000006677 Monarda citriodora ssp. austromontana Nutrition 0.000 description 1
- 240000007673 Origanum vulgare Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000001789 adipocyte Anatomy 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 210000004913 chyme Anatomy 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 230000025507 digestive system development Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 150000002711 medium chain fatty acid esters Chemical class 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000004798 organs belonging to the digestive system Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 239000004460 silage Substances 0.000 description 1
- 210000004894 snout Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
- A23K20/147—Polymeric derivatives, e.g. peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/30—Oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P60/00—Technologies relating to agriculture, livestock or agroalimentary industries
- Y02P60/80—Food processing, e.g. use of renewable energies or variable speed drives in handling, conveying or stacking
- Y02P60/87—Re-use of by-products of food processing for fodder production
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Birds (AREA)
- Inorganic Chemistry (AREA)
- Fodder In General (AREA)
Abstract
The invention provides a functional compound for promoting piglet growth and a preparation method and application thereof, wherein the functional compound comprises 30-50 parts of piglet structural fat, 1-10 parts of inulin short-chain fatty acid ester, 1-10 parts of polysaccharide compound, 1-5 parts of glycine iron and 1-5 parts of phytase by weight; the raw materials for preparing the piglet structure fat comprise 1, 3-dioleic acid-2-medium chain fatty acid triglyceride, coix seed oil and chili oil. The functional compound provided by the invention can promote the growth and development of intestinal villi of piglets, maintain the health of intestinal tracts, improve the digestion and absorption capacity of the piglets on nutrient substances, reduce diarrhea, avoid the anemia problem of the piglets and effectively promote the growth of the piglets.
Description
Technical Field
The invention belongs to the technical field of feeds, and particularly relates to a functional compound for promoting piglet growth, a preparation method and an application thereof, in particular to a functional compound for promoting piglet growth and capable of promoting piglet intestinal villus development, and a preparation method and an application thereof.
Background
Due to the continuous progress of modern breeding technology, the weaning days of piglets are gradually advanced. The daily ration of the weaned piglets is changed from breast milk to solid or liquid feed, but the digestive system development of the piglets is not complete, the structure of the exogenous feed is different from that of the breast milk, and the exogenous feed is not easy to be digested and absorbed, so that the dyspepsia, the immunity and the disease resistance of the piglets are reduced, even the diarrhea is caused, and the great economic loss is brought to the pig raising production.
The intestinal tract is not only the digestive organs of animals, but also the largest endocrine organs in the body. Before and after the pigs are weaned, the structure and the function of the intestinal tract are greatly changed, and the stress can cause the internal organs and tissues of the piglets to be pathologically damaged, the intestinal villus is atrophied, the indigestion and malabsorption are caused, and the inflammation is caused.
CN108902515A discloses a feed premix for increasing piglet intestinal villus height and reducing crypt depth, and a preparation method and application thereof, wherein each 100 parts by weight of the feed premix comprises 20-40 parts by weight of silage straw, 15-35 parts by weight of intestinal membrane protein, 10-25 parts by weight of citric acid, 10-20 parts by weight of glucose, 4-9 parts by weight of oregano extract, 5-10 parts by weight of beer yeast, 2-5 parts by weight of salt, and the balance of carrier. The effective viable bacteria content in per g of cerevisiae Fermentum is 7 × 10 9 -7.5×10 9 And (4) CFU. The feed premix does not generate drug resistance, and the raw material components are matched and used with good and stable effect. The preparation method mixes the raw materials according to the proportion, is simple and quick, and has good feed stability. The feed premix is added into a weaned piglet feed to improve the intestinal function of piglets, regulate the intestinal health, enhance the immunity and effectively improve the growth performance of the piglets.
CN106135691A discloses a feed additive for promoting intestinal health of piglets, which comprises the following raw materials in parts by weight: 10-15 parts of yeast fermentation culture, 8-12 parts of coix seed, 10-15 parts of composite plant extract, 6-8 parts of galangal and 12-16 parts of fingered citron. The additive is applied to piglets, and can promote intestinal villus development of piglets, increase beneficial bacteria flora quantity in intestinal tract, improve intestinal mucosa immunity, improve piglet growth performance, reduce diarrhea rate, and significantly improve breeding benefit. Meanwhile, the feed additive also has the function of replacing antibiotics, and has important significance for promoting the development of live pig breeding industry towards green and safe direction.
Due to the fact that the requirements for nutrients of the piglets after weaning are high, the conventional feed is often lack of the important functional nutrients, and therefore intestinal tracts of the piglets are damaged and grow slowly. Therefore, how to provide a functional compound which can rapidly provide energy and high-quality nutrition for the intestinal tracts of piglets, relieve the damage of the intestinal barrier function, repair the intestinal villus structure and promote the growth of the intestinal villus of the piglets, thereby improving the digestion and utilization rate of the piglets on nutrient substances and promoting the rapid growth of the piglets becomes a problem to be solved urgently.
Disclosure of Invention
Aiming at the defects of the prior art, the invention aims to provide a functional compound for promoting the growth of piglets and a preparation method and application thereof, and particularly provides a functional compound for promoting the growth of piglets, which can promote the development of intestinal villi of the piglets, and a preparation method and application thereof. The functional compound provided by the invention can effectively promote the growth and development of intestinal villi of piglets, maintain the intestinal health of piglets, reduce the diarrhea condition, improve the digestion and absorption capacity of the piglets on nutrient substances, and avoid the anemia problem of the piglets, thereby promoting the rapid growth of the piglets.
In order to achieve the purpose, the invention adopts the following technical scheme:
according to the first aspect, the invention provides a functional compound for promoting growth of piglets, which comprises 30-50 parts of piglet structural fat, 1-10 parts of inulin short-chain fatty acid ester, 1-10 parts of polysaccharide compound, 1-5 parts of glycine iron and 1-5 parts of phytase by weight.
The preparation raw materials of the piglet structure fat comprise 1, 3-dioleic acid-2-medium chain fatty acid triglyceride (OMO type structure ester), coix seed oil and chili oil.
The piglet structural fat can be 30 parts, 35 parts, 40 parts, 45 parts or 50 parts, the inulin short-chain fatty acid ester can be 1 part, 3 parts, 5 parts, 7 parts, 9 parts or 10 parts, the polysaccharide complex can be 1 part, 3 parts, 5 parts, 7 parts, 9 parts or 10 parts, the glycine iron can be 1 part, 2 parts, 3 parts, 4 parts or 5 parts, the phytase can be 1 part, 2 parts, 3 parts, 4 parts or 5 parts, but the method is not limited to the above-mentioned numerical values, and other numerical values in the above-mentioned numerical value range can be also applied.
The functional compound is compounded by adopting three compounds of piglet structural fat, inulin short-chain fatty acid ester and polysaccharide compound, and the synergistic effect can effectively promote the growth and development of piglet intestinal villi, maintain the piglet intestinal health, improve the digestion and absorption capacity of piglets on nutrient substances, promote the piglet growth and reduce the diarrhea condition; the iron glycinate and the phytase are compounded, so that the anemia problem of piglets can be avoided, and the apoptosis of intestinal cells can be reduced, so that the intestinal barrier function damage is relieved; and the 1, 3-dioleic acid-2-medium chain fatty acid triglyceride, the coix seed oil and the chili oil are compounded, so that the effect of the piglet structure fat can be further improved.
The OMO-type structural ester is a symmetrical medium-long chain triglyceride containing oleic acid at the sn-1 and 3 positions and medium-chain fatty acids at the sn-2 position, which is helpful for absorption of nutrients, and the medium-chain fatty acids are more easily digested and metabolized in the body than the long-chain fatty acids. After entering human body, the sn-1, 3-position oleic acid is hydrolyzed, the medium chain fatty acid in the form of sn-2 monoglyceride can be directly absorbed without being re-esterified into triglyceride, and has the effect of fast energy supply compared with the common medium chain fatty acid ester; while medium and long chain triglycerides differ in their metabolic pathways in the body. Long chain triglycerides are broken down and transported to mucosal cells via lymph to form new triglycerides. While medium chain triglycerides are hydrolyzed by lipases to medium chain fatty acids, which enter the liver via the portal vein and are oxidized to H in the liver 2 O、CO 2 And energy or carcass formation, not readily storable in adipocytes or liver tissue; the OMO type structural ester combines the two advantages, and has the effects of rapidly supplying energy and promoting piglet production.
Preferably, the raw materials for preparing the piglet structure fat comprise 60-80 parts of 1, 3-dioleic acid-2-medium chain fatty acid triglyceride, 1-5 parts of coix seed oil and 1-10 parts of chili oil in parts by weight.
The number of parts of the 1, 3-dioleoyl-2-medium-chain fatty acid triglyceride may be 60 parts, 65 parts, 70 parts, 75 parts, or 80 parts, the number of parts of the coix seed oil may be 1 part, 2 parts, 3 parts, 4 parts, or 5 parts, and the number of parts of the capsicum oil may be 1 part, 2 parts, 3 parts, 4 parts, 5 parts, 6 parts, 7 parts, 8 parts, 9 parts, or 10 parts, but is not limited to the above-mentioned values, and other values not listed in the above-mentioned numerical range may be similarly applied.
Preferably, the raw materials for preparing the piglet structure fat also comprise a carrier.
Preferably, the piglet structural fat is prepared by a method comprising the following steps: heating and dissolving 1, 3-dioleic acid-2-medium chain fatty acid triglyceride, coix seed oil and chili oil, mixing with carrier, spraying, and drying to obtain the piglet structure fat.
Preferably, the 1, 3-dioleoyl-2-medium chain fatty acid triglycerides include 1, 3-dioleoyl-2-caprylic triglyceride, 1, 3-dioleoyl-2-capric triglyceride, 1, 3-dioleoyl-2-lauric triglyceride, and 1, 3-dioleoyl-2-myristic triglyceride.
Preferably, the mass ratio of the 1, 3-dioleic-2-caprylic triglyceride, 1, 3-dioleic-2-capric triglyceride, 1, 3-dioleic-2-lauric triglyceride and 1, 3-dioleic-2-myristic triglyceride is (1-3): 1-5): 1-2): 3-5, wherein the part of the 1, 3-dioleic-2-caprylic triglyceride can be 1, 2 or 3, etc., the part of the 1, 3-dioleic-2-capric triglyceride can be 1, 2, 3, 4 or 5, etc., the part of the 1, 3-dioleic-2-lauric triglyceride can be 1, 1.5 or 2, etc., the part of the 1, 3-dioleic-2-myristic triglyceride can be 3, 3, 4, 5, etc., but are not limited to the numerical values recited above, and other numerical values not recited within the above numerical ranges are also applicable.
The 1, 3-dioleoyl-2-medium chain fatty acid triglyceride is compounded by adopting specific four components, and the synergistic effect can effectively improve the effect of the 1, 3-dioleoyl-2-medium chain fatty acid triglyceride.
Preferably, the carrier includes any one or a combination of at least two of casein, lactose or soy protein isolate, such as a combination of casein and lactose, a combination of lactose and soy protein isolate or a combination of casein and soy protein isolate, etc., but is not limited to the above-listed combinations, and other combinations not listed within the above-mentioned combinations are equally applicable.
Preferably, the carrier is a combination of casein, lactose, soy protein isolate.
Preferably, the mass ratio of casein, lactose and soy protein isolate is (1-3): 1-2):1, for example 1:1:1, 2:2:1 or 3:1:1, but not limited to the above-listed values, and other values not listed in the above-mentioned range of values are equally applicable.
Preferably, the mass ratio of the total mass of the 1, 3-dioleoyl-2-medium chain fatty acid triglyceride, the coix seed oil and the chilli oil to the carrier is (2-3) to (2-3), for example, 2:3, 2.5:2.5 or 3:2, but is not limited to the above-listed values, and other values not listed in the above-mentioned value range are also applicable.
Preferably, the inulin short-chain fatty acid ester includes inulin acetate, inulin propionate and inulin butyrate ester.
Preferably, the mass ratio of the inulin acetate, the inulin propionate and the inulin butyrate is (9-15): (5-8): (3-5), wherein the part of the inulin acetate can be 9, 10, 11, 12, 13, 14 or 15, etc., the part of the inulin propionate can be 5, 6, 7 or 8, etc., and the part of the inulin butyrate can be 3, 4 or 5, etc., but is not limited to the above-listed values, and other values not listed in the above-mentioned numerical range are also applicable.
The inulin short-chain fatty acid ester is compounded by inulin acetate, inulin propionate and inulin butyrate, and the effect of the inulin short-chain fatty acid ester can be further improved under the synergistic effect.
The inulin short-chain fatty acid is not easy to digest in oral cavity and stomach small intestine, and is decomposed into inulin and short-chain fatty acid after reaching the small intestine, the short-chain fatty acid can provide energy for small intestine epithelium to promote intestinal villus development, and the inulin is fermented under the action of a large amount of beneficial bacteria after reaching colon to generate SCFA.
The inulin short-chain fatty acid supplement not only improves the defect of directly supplementing short-chain fatty acid (SCFA), conveys the SCFA to the intestinal tract to promote the growth and development of intestinal villi of piglets, but also provides high-quality fiber for piglets, promotes the proliferation of intestinal probiotics such as bifidobacterium, lactobacillus and the like, and improves the intestinal flora, promotes the growth and development of intestinal villi of piglets, mineral absorption and the like by virtue of the SCFA produced by fermentation under the action of intestinal microorganisms.
Preferably, the inulin short-chain fatty acid ester has an average degree of polymerization of not more than 5, such as 5, 4, 3 or 2, etc., but not limited to the above-listed values, and other values not listed within the above-mentioned range of values are equally applicable.
Preferably, the polysaccharide complex comprises hericium erinaceus polysaccharide, lentinan, rosa roxburghii polysaccharide and alfalfa polysaccharide.
Preferably, the ratio of the hericium erinaceus polysaccharide to the lentinan to the rosa roxburghii polysaccharide to the alfalfa polysaccharide is (3-5): (1-2): (3-7): (2-4), wherein the part of the hericium erinaceus polysaccharide can be 3, 4 or 5, etc., the part of the lentinan can be 1, 1.5 or 2, etc., the part of the rosa roxburghii polysaccharide can be 3, 4, 5, 6 or 7, etc., and the part of the alfalfa polysaccharide can be 2, 3 or 4, etc., but is not limited to the above-listed values, and other values not listed in the above-mentioned range of values are also applicable.
The polysaccharide compound is prepared by compounding hericium erinaceus polysaccharide, lentinan, rosa roxburghii tratt polysaccharide and alfalfa polysaccharide, so that the effect of the polysaccharide compound can be further improved; can be used as prebiotics in intestinal tract to stimulate intestinal tract mucosa immune system to make immune response, and can interact with intestinal tract microorganism to improve intestinal tract environment and intestinal tract flora structure. Can also promote the growth of intestinal villi and maintain the integrity and balance of mucous membranes of intestinal flora, thereby effectively reducing the incidence of diseases.
In a second aspect, the present invention provides a method for preparing a functional complex as described above, comprising the steps of:
and mixing piglet structural fat, inulin short-chain fatty acid ester, polysaccharide complex, glycine iron and phytase to obtain the functional complex.
In a third aspect, the invention also provides an application of the functional compound in preparing piglet feed.
Compared with the prior art, the invention has the following beneficial effects:
the invention provides a functional compound for promoting the growth of piglets, which can effectively promote the growth and development of intestinal villi of the piglets, maintain the intestinal health of the piglets, improve the digestion and absorption capacity of the piglets on nutrient substances, promote the growth of the piglets and reduce the diarrhea condition by adopting the compounding of piglet structural fat, inulin short-chain fatty acid ester and polysaccharide compound and the synergistic action; and the compound of the glycine iron and the phytase effectively improves the iron absorption rate of piglets, avoids anemia of the piglets, protects intestinal cells, reduces the apoptosis of the intestinal cells, thereby alleviating the damage of the intestinal barrier function, further maintaining the intestinal health of the piglets and promoting the rapid growth of the piglets.
Detailed Description
To further illustrate the technical means and effects of the present invention, the following preferred embodiments of the present invention are further described, but the present invention is not limited to the scope of the embodiments.
In the following examples, coix seed oil was purchased from shanghai brocade toona sinensis biotechnology limited;
the chili oil is purchased from Shanghai brocade toona sinensis Biotech Co., Ltd;
soy protein isolate was purchased from heinan old shellfish biotechnology limited;
inulin acetate was purchased from gardley biochemical technologies, ltd, guangzhou;
inulin propionate was purchased from Guangzhou Jiadeli Biochemical technology, Inc.;
inulin butyrate was purchased from gardley biochemical technologies, ltd, guangzhou;
hericium erinaceus polysaccharides were purchased from Hibiscus biosciences, Inc;
lentinan was purchased from Hibiscus Shinit Biotech, Inc.;
rosa roxburghii polysaccharide is purchased from Hibiscus parnaschii Biotech Co., Ltd;
alfalfa polysaccharide was purchased from downy snout biotechnology limited;
phytase was purchased from Hibiscus Sainus Biotech, Inc.
The parts are in the following examples by weight.
Preparation example 1
The preparation example provides a piglet structure fat, and the preparation method comprises the following steps:
the piglet structure fat is obtained by fully mixing 14 parts of 1, 3-dioleic acid-2-caprylic triglyceride, 21 parts of 1, 3-dioleic acid-2-capric triglyceride, 7 parts of 1, 3-dioleic acid-2-lauric triglyceride, 28 parts of 1, 3-dioleic acid-2-myristic triglyceride, 3 parts of coix seed oil, 5 parts of chili oil, 26 parts of casein, 26 parts of lactose and 26 parts of isolated soy protein, and then carrying out spray drying.
Preparation example 2
This preparation provides a piglet structured fat, which is the same as in preparation example 1 except that 1, 3-dioleic acid-2-decanoic acid triglyceride is not included in the preparation, and a reduced portion is proportionally allocated to 1, 3-dioleic acid-2-octanoic acid triglyceride, 1, 3-dioleic acid-2-lauric acid triglyceride and 1, 3-dioleic acid-2-myristic acid triglyceride.
Preparation example 3
This preparation example provides a piglet structured fat, which was the same as in preparation example 1 except that 1, 3-dioleic-2-lauric triglyceride was not included and a reduced portion was proportionally allocated to 1, 3-dioleic-2-capric triglyceride, 1, 3-dioleic-2-caprylic triglyceride and 1, 3-dioleic-2-myristic triglyceride.
Preparation example 4
This preparation provides a piglet structured fat, which is identical to preparation example 1 except that 1, 3-dioleic acid-2-myristoleic acid triglyceride is not included in the preparation, and a reduced portion is proportionally allocated to 1, 3-dioleic acid-2-decanoic acid triglyceride, 1, 3-dioleic acid-2-lauric acid triglyceride and 1, 3-dioleic acid-2-caprylic acid triglyceride.
Preparation example 5
This preparation provides a piglet structured fat, which is the same as in preparation example 1 except that 1, 3-dioleate-2-caprylic triglyceride is not included in the preparation, and a reduced portion is proportionally distributed to 1, 3-dioleate-2-myristic triglyceride, 1, 3-dioleate-2-capric triglyceride and 1, 3-dioleate-2-lauric triglyceride.
Preparation example 6
The preparation example provides a piglet structure fat, and the preparation method is the same as the preparation example 1 except that the coix seed oil is not contained, and the part of the coix seed oil is reduced and distributed to the chili oil.
Preparation example 7
The preparation example provides a piglet structure fat, and the preparation method is the same as the preparation example 1 except that the piglet structure fat does not contain chili oil and the reduced part of the chili oil is distributed to the coix seed oil.
Preparation example 8
This preparation example provides a piglet structured fat, which is the same as preparation example 1 except that it does not contain 1, 3-dioleate-2-caprylic triglyceride, 1, 3-dioleate-2-myristic triglyceride, 1, 3-dioleate-2-capric triglyceride and 1, 3-dioleate-2-lauric triglyceride.
Example 1
This example provides a functional complex prepared from the following raw materials:
40 parts of piglet structure fat, 2.7 parts of inulin acetate, 1.4 parts of inulin propionate, 0.9 part of inulin butyrate, 1.5 parts of hericium erinaceus polysaccharide, 0.5 part of lentinan, 1.9 parts of rosa roxburghii tratt polysaccharide, 1.1 parts of alfalfa polysaccharide, 3 parts of ferric glycinate and 3 parts of phytase, which are provided by the preparation example 1.
The preparation method comprises the following steps:
and mixing the above raw materials to obtain the functional compound.
Example 2
This example provides a functional complex prepared from the following raw materials:
50 parts of piglet structural fat provided by preparation example 1, 0.54 part of inulin acetate, 0.29 part of inulin propionate, 0.17 part of inulin butyrate, 3.33 parts of hericium erinaceus polysaccharide, 1.11 parts of lentinan, 3.33 parts of rosa roxburghii tratt polysaccharide, 2.23 parts of alfalfa polysaccharide, 5 parts of glycine iron and 1 part of phytase.
The preparation method is the same as example 1.
Example 3
This example provides a functional complex prepared from the following raw materials:
30 parts of piglet structural fat, 5.3 parts of inulin acetate, 2.9 parts of inulin propionate, 1.8 parts of inulin butyrate, 0.27 part of hericium erinaceus polysaccharide, 0.11 part of lentinan, 0.39 part of rosa roxburghii tratt polysaccharide, 0.23 part of alfalfa polysaccharide, 1 part of glycine iron and 5 parts of phytase provided by preparation example 1.
The preparation method is the same as example 1.
Examples 4 to 10
Examples 4-13 each provide a functional complex, the starting materials for which are identical to those of example 1, except that the piglet structural fat provided in preparation example 1 is replaced with an equivalent amount of the piglet structural fat provided in preparation examples 2-8, respectively.
The preparation method is the same as example 1.
Example 11
This example provides a functional complex, which is identical to that of example 1, except that no inulin butyrate is added, and a reduced fraction is apportioned to inulin acetate, inulin propionate.
The preparation method is the same as example 1.
Example 12
This example provides a functional complex, which is identical to that of example 1, except that no inulin acetate is added, and a reduced fraction is apportioned to the butyrate and propionate inulin esters.
The preparation method is the same as example 1.
Example 13
This example provides a functional complex, which is identical to that of example 1, except that no alanate is added, and a reduced fraction is apportioned to alanate acetate and alanate butyrate.
The preparation method is the same as example 1.
Example 14
This example provides a functional complex, which is identical to example 1 except that no hericium erinaceus polysaccharide is added, and the reduced fraction is proportionally distributed to lentinan, rosa roxburghii tratt, alfalfa polysaccharide.
The preparation method is the same as example 1.
Example 15
The embodiment provides a functional compound, and the specific steps are the same as the embodiment 1 except that lentinan is not added, and the reduced part is proportionally distributed to hericium erinaceus polysaccharide, rosa roxburghii tratt polysaccharide and alfalfa polysaccharide.
The preparation method is the same as example 1.
Example 16
The embodiment provides a functional compound, and the specific steps are the same as the embodiment 1 except that no rosa roxburghii polysaccharide is added, and the reduced parts are proportionally distributed to lentinan, hericium erinaceus polysaccharide and alfalfa polysaccharide.
The preparation method is the same as example 1.
Example 17
The embodiment provides a functional compound, and the specific steps are the same as those of the embodiment 1 except that alfalfa polysaccharide is not added, and the reduced part is proportionally distributed to lentinan, rosa roxburghii tratt polysaccharide and hericium erinaceus polysaccharide.
The preparation method is the same as example 1.
Comparative example 1
This comparative example provides a functional complex, which was identical to that of example 1 except that no piglet structural lipids provided in preparation example 1 were added, and the reduced fractions were proportionally distributed to inulin acetate, inulin propionate, inulin butyrate, simian polysaccharide, lentinan, rosa roxburghii polysaccharide, alfalfa polysaccharide.
The preparation method is the same as example 1.
Comparative example 2
The comparative example provides a functional complex, which is identical to example 1 except that inulin acetate, inulin propionate and inulin butyrate are not added in the specific steps, and a reduced part is proportionally distributed to piglet structure fat, simian cephem polysaccharide, lentinan, roxburgh rose polysaccharide and alfalfa polysaccharide provided in preparation example 1.
The preparation method is the same as example 1.
Comparative example 3
The comparative example provides a functional complex, and the specific steps are the same as those in example 1 except that hericium erinaceus polysaccharide, lentinan, rosa roxburghii tratt polysaccharide and alfalfa polysaccharide are not added, and the reduced part is proportionally distributed to inulin acetate, inulin propionate and inulin butyrate and the piglet structure fat provided in preparation example 1.
The preparation method is the same as example 1.
And (3) effect testing:
567 healthy and 7 kg-weight Du-Dai three-way hybrid weaned pigs were selected, randomly and evenly divided into 21 groups, each group had 3 replicates, 9 replicates each, and fed with commercial piglet feed mix (Aaonong Biotech Co., Ltd., Guangzhou, control group) and 5% of the functional compound provided in examples 1-17 and comparative examples 1-3, respectively, on the basis of the commercial piglet feed mix, the test period was 49 days, and 1 piglet with the weight closest to the average weight of the group was selected and labeled for each group, and was slaughtered in order. Collecting tissues of duodenum (1cm), jejunum (3cm) and ileum (2cm), washing with normal saline, and fixing in 4% paraformaldehyde solution; collecting duodenal mucosa and jejunum mucosa samples and colon and caecum chyme samples, quickly freezing by using liquid nitrogen, and storing in a refrigerator at the temperature of minus 80 ℃ to be tested.
Intestinal tract morphological structure
Samples of duodenum, jejunum and ileum fixed by 4% paraformaldehyde are taken out to be prepared into paraffin sections, then hematoxylin-eosin (HE) staining is carried out, Image acquisition is carried out under a microscope after dehydration and mounting, the height of villus and the depth of crypt of each intestinal section are measured by using Image-pro plus 6.0 software and taking a 40-fold scale as a standard, and the height/depth of the villus are calculated.
The daily gain, feed ratio, diarrhea rate and intestinal tract morphological structure of piglets are recorded, and the average value is calculated, and the result is as follows:
compared with the control group, the product provided by the invention can effectively promote the growth and development of intestinal villi of piglets, improve the digestion and absorption capacity of the piglets on feed, promote the growth of the piglets and reduce the diarrhea condition; comparing examples 1 and 4-7, the invention can find that the efficacy of the OMO type structural ester can be further improved by the synergistic effect of the compound of 1, 3-dioleic acid-2-caprylic triglyceride, 1, 3-dioleic acid-2-capric triglyceride, 1, 3-dioleic acid-2-lauric triglyceride and 1, 3-dioleic acid-2-myristic triglyceride; comparing examples 1 and 8-10, the invention can find that the efficacy of piglet structure fat can be further improved by adopting the compounding of the OMO type structure ester, the coix seed oil and the chili oil and the synergistic effect; compared with the examples 1 and 11-13, the invention can find that the effect of the inulin short-chain fatty acid ester can be effectively improved by adopting the compounding of the inulin propionate, the inulin acetate and the inulin butyrate and the synergistic effect; compared with the embodiments 1 and 14-17, the invention can find that the effect of the polysaccharide complex can be improved by adopting the compounding of the lentinan, the rosa roxburghii tratt polysaccharide, the hericium erinaceus polysaccharide and the alfalfa polysaccharide and the synergistic effect; compared with the embodiment 1 and the comparative examples 1-3, the piglet feed additive disclosed by the invention has the advantages that the specific piglet structural fat, the inulin short-chain fatty acid ester and the polysaccharide compound are compounded and have a synergistic effect, so that the growth and development of piglet intestinal villi are effectively promoted, the ratio of the height of the villi to the depth of a crypt is improved, the digestion and absorption capacity of piglets on the feed is improved, the feed ratio is reduced, the growth of piglets is promoted, and the diarrhea condition is reduced.
The applicant states that the functional compound for promoting piglet growth and the preparation method and application thereof are illustrated by the above examples, but the invention is not limited to the above examples, i.e. the invention is not limited to be implemented by the above examples. It should be understood by those skilled in the art that any modifications to the present invention, equivalent substitutions of the raw materials of the product of the present invention, and the addition of auxiliary components, selection of specific modes, etc., are within the scope and disclosure of the present invention.
The preferred embodiments of the present invention have been described in detail, however, the present invention is not limited to the specific details of the above embodiments, and various simple modifications may be made to the technical solution of the present invention within the technical idea of the present invention, and these simple modifications all fall within the protection scope of the present invention.
It should be noted that the technical features described in the above embodiments can be combined in any suitable manner without contradiction, and various possible combinations of the features are not described in order to avoid unnecessary repetition.
Claims (10)
1. The functional compound for promoting the growth of the piglets is characterized by comprising 30-50 parts of piglet structural fat, 1-10 parts of inulin short-chain fatty acid ester, 1-10 parts of polysaccharide compound, 1-5 parts of glycine iron and 1-5 parts of phytase by weight;
the raw materials for preparing the piglet structure fat comprise 1, 3-dioleic acid-2-medium chain fatty acid triglyceride, coix seed oil and chili oil.
2. The functional compound as claimed in claim 1, wherein the raw materials for preparing piglet structural fat comprise, by weight, 60-80 parts of 1, 3-dioleate-2-medium chain fatty acid triglyceride, 1-5 parts of coix seed oil and 1-10 parts of chili oil;
preferably, the raw materials for preparing the piglet structure fat also comprise a carrier;
preferably, the piglet structural fat is prepared by a method comprising the following steps: heating and dissolving 1, 3-dioleic acid-2-medium chain fatty acid triglyceride, coix seed oil and chili oil, mixing with carrier, spraying, and drying to obtain the piglet structure fat.
3. The functional complex of claim 1 or 2, wherein the 1, 3-dioleic-2-medium chain fatty acid triglycerides comprise 1, 3-dioleic-2-caprylic acid triglyceride, 1, 3-dioleic-2-capric acid triglyceride, 1, 3-dioleic-2-lauric acid triglyceride, and 1, 3-dioleic-2-myristic acid triglyceride;
preferably, the mass ratio of the 1, 3-dioleic-2-caprylic acid triglyceride, the 1, 3-dioleic-2-capric acid triglyceride, the 1, 3-dioleic-2-lauric acid triglyceride and the 1, 3-dioleic-2-myristic acid triglyceride is (1-3): (1-5): (1-2): (3-5).
4. The functional complex of claim 2 or 3, wherein the carrier comprises any one of casein, lactose or soy protein isolate or a combination of at least two thereof;
preferably, the carrier is a combination of casein, lactose, soy protein isolate;
preferably, the mass ratio of the casein to the lactose to the soy protein isolate is (1-3) to (1-2) to 1.
5. The functional complex according to any one of claims 2 to 4, wherein the total mass of the 1, 3-dioleoyl-2-medium chain fatty acid triglyceride, the coix seed oil, the capsicum oil and the carrier is in a mass ratio of (2-3) to (2-3).
6. The functional complex according to any of claims 1-5, wherein the inulin short-chain fatty acid ester comprises inulin acetate, inulin propionate and inulin butyrate;
preferably, the mass ratio of the inulin acetate, the inulin propionate and the inulin butyrate is (9-15): (5-8): (3-5).
7. The functional complex according to any of claims 1-6, wherein the inulin short-chain fatty acid ester has an average degree of polymerization of not more than 5.
8. The functional complex according to any one of claims 1 to 7, wherein the polysaccharide complex comprises Hericium erinaceus polysaccharide, lentinan, Rosa roxburghii polysaccharide and alfalfa polysaccharide;
preferably, the mass ratio of the hericium erinaceus polysaccharide to the lentinan to the rosa roxburghii polysaccharide to the alfalfa polysaccharide is (3-5): 1-2): 3-7): 2-4.
9. A method for preparing a functional complex according to any of claims 1 to 8, comprising the steps of:
and mixing piglet structural fat, inulin short-chain fatty acid ester, polysaccharide complex, glycine iron and phytase to obtain the functional complex.
10. Use of a functional complex according to any one of claims 1-8 for the preparation of a piglet feed.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210672320.6A CN115024412A (en) | 2022-06-14 | 2022-06-14 | Functional compound for promoting growth of piglets and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210672320.6A CN115024412A (en) | 2022-06-14 | 2022-06-14 | Functional compound for promoting growth of piglets and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN115024412A true CN115024412A (en) | 2022-09-09 |
Family
ID=83124385
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210672320.6A Pending CN115024412A (en) | 2022-06-14 | 2022-06-14 | Functional compound for promoting growth of piglets and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115024412A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110008388A1 (en) * | 2007-07-03 | 2011-01-13 | Novus International Inc. | Piglet feed rations having low levels of fermentable carbohydrates |
CN108378235A (en) * | 2018-02-13 | 2018-08-10 | 广州市优百特饲料科技有限公司 | A kind of suckling piglet milk powder high in fat and preparation method thereof |
WO2019098823A1 (en) * | 2017-11-14 | 2019-05-23 | Ausnutria Hyproca B.V. | Composition comprising a2 b-casein and a vegetable fat mixture |
CN110353101A (en) * | 2019-07-30 | 2019-10-22 | 广州市优百特饲料科技有限公司 | One boar fatty powder and its preparation method and application |
CN111345402A (en) * | 2020-03-25 | 2020-06-30 | 广州市优百特饲料科技有限公司 | Functional additive and preparation method and application thereof |
CN113632888A (en) * | 2021-08-10 | 2021-11-12 | 广州朴成生物科技有限公司 | Functional additive for reducing weaning stress of piglets and preparation method and application thereof |
-
2022
- 2022-06-14 CN CN202210672320.6A patent/CN115024412A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110008388A1 (en) * | 2007-07-03 | 2011-01-13 | Novus International Inc. | Piglet feed rations having low levels of fermentable carbohydrates |
WO2019098823A1 (en) * | 2017-11-14 | 2019-05-23 | Ausnutria Hyproca B.V. | Composition comprising a2 b-casein and a vegetable fat mixture |
CN108378235A (en) * | 2018-02-13 | 2018-08-10 | 广州市优百特饲料科技有限公司 | A kind of suckling piglet milk powder high in fat and preparation method thereof |
CN110353101A (en) * | 2019-07-30 | 2019-10-22 | 广州市优百特饲料科技有限公司 | One boar fatty powder and its preparation method and application |
CN111345402A (en) * | 2020-03-25 | 2020-06-30 | 广州市优百特饲料科技有限公司 | Functional additive and preparation method and application thereof |
CN113632888A (en) * | 2021-08-10 | 2021-11-12 | 广州朴成生物科技有限公司 | Functional additive for reducing weaning stress of piglets and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102669448B (en) | Low-energy feed for meat chicken and preparation method thereof | |
CN104186926A (en) | Method for preparing cinnamon biological feed with effects of promoting appetite and improving immunity | |
CN109315586B (en) | Preparation method and application of fermented Chinese herbal medicine biological feed for ruminants | |
WO2015090204A1 (en) | Method for producing biological feed additive using cassava residue and ethanol waste mash | |
CN110432391B (en) | Feed additive for regulating and controlling rumen metabolism of ruminant and preparation method thereof | |
CN110178974B (en) | Feed additive, feed and preparation method thereof | |
CN114617202A (en) | Compound microecological preparation for improving disease resistance and production performance of ducks as well as preparation method and application of compound microecological preparation | |
CN107455562B (en) | Pig feed produced by using rice bran oil to replace soybean oil | |
CN112841402A (en) | Preparation method and application of fermented feed | |
CN115024412A (en) | Functional compound for promoting growth of piglets and preparation method and application thereof | |
CN111280307A (en) | Additive for soybean meal fermentation and application of additive in feed | |
CN115152892B (en) | Method for degrading free gossypol in cottonseed meal, product and application thereof | |
CN113229369B (en) | sn-2 saturated fatty acid active structured lipid composition and preparation method and application thereof | |
CN112369353B (en) | Culture method for improving effect of replacing feed by part of turbot juvenile plant protein | |
CN1759715A (en) | Direct placing on production of brewery mash and production method | |
CN112401089A (en) | Novel feed capable of improving bighead carp breeding density and preparation method thereof | |
CN111149919A (en) | Glycerol butyrate compound for poultry as well as preparation method and application thereof | |
CN112586598A (en) | Preparation method of biological feed for improving livestock and poultry production performance | |
CN112753882A (en) | Feed for improving egg quality of laying hens in egg producing period and preparation method thereof | |
CN111728081A (en) | Compound bacterium fermentation liquor for feed additive and preparation method thereof | |
CN111165680A (en) | Composite probiotic feed additive for geese and preparation method and application thereof | |
CN105981923A (en) | Feed for portunus trituberculatus, and preparation and use methods for same | |
CN113337447B (en) | Complex microbial inoculant, fermented feed, application and preparation method | |
CN115005159B (en) | Breeding method for maintaining intestinal health of piglets and application thereof | |
CN117044847B (en) | California perch feed and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220909 |
|
RJ01 | Rejection of invention patent application after publication |